Sophia Rahman, MD
Internal Medicine · Plano, TXNPI 1306142955
Payments from drug & device makers
Across 346 payments — averaging $9607.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$3.2M
- AbbVie$114K
- Bayer$28K
- Novo Nordisk$651
- Amarin Pharma, Inc.$285
- GSK$242
- plus $2K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 102 | $3,179,168 |
| AbbVie(2 entities) | 62 | $114,299 |
| Bayer | 13 | $27,953 |
| Novo Nordisk | 51 | $651 |
| Amarin Pharma, Inc. | 19 | $285 |
| GSK | 17 | $242 |
| Lilly USA, LLC | 16 | $229 |
| Merck | 12 | $176 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $137 |
| Eyepoint US, Inc. | 1 | $103 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $100 |
| Kowa Pharmaceuticals America, Inc. | 6 | $98 |
| Amneal Pharmaceuticals LLC | 6 | $86 |
| AstraZeneca | 6 | $85 |
| Medtronic(2 entities) | 4 | $77 |
| Astellas Pharma US Inc | 5 | $76 |
| Genentech USA, Inc. | 3 | $55 |
| Pfizer | 2 | $48 |
| Exact Sciences | 2 | $31 |
| Boehringer Ingelheim | 2 | $29 |
| Bardy Diagnostics, Inc. | 1 | $25 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Coloplast | 1 | $22 |
| Sanofi | 1 | $21 |
| Advanced Accelerator Applications | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
How this compares
$3,324,149 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Plano
- Saumil MehtaPlano$5.4M
- Tanvir AhmadPlano$3.5M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.